Apryl has raised $4.0M in total across 1 funding round.
Apryl's investors include Breega.
Apryl is a Berlin-based technology company specializing in fertility and family-planning benefits as a workplace perk. It provides a platform that offers employees unlimited consultations on fertility and family planning, access to clinics and treatments, and manages employer reimbursements. Apryl primarily serves employers who want to support their workforce with inclusive and accessible fertility benefits, addressing the growing need for reproductive health support in the workplace. The company has shown strong growth momentum, having raised $4.4 million in seed funding and securing partnerships with firms like the period tracking app Clue to enhance its service offerings[1][3].
Apryl was co-founded by Jenny Saft and Tobias Caterba, who initially launched the company as Oviavo, a direct-to-consumer platform focused on egg freezing. They soon pivoted to a B2B model, targeting employers to provide fertility benefits as part of employee perks, recognizing a broader need for accessible reproductive treatments. The idea emerged from observing the established fertility benefits market in the US and aiming to replicate and expand this model in Europe, where such benefits are just beginning to gain traction. Early traction included raising significant seed funding and forming strategic partnerships, positioning Apryl as a leading fertility benefits provider in Europe[1][2].
Apryl rides the growing trend of integrating health and wellness benefits into employee compensation packages, particularly focusing on fertility and family planning—a sector gaining importance due to demographic shifts and increasing awareness of reproductive health. The timing is critical as European employers begin to adopt benefits long standard in the US, driven by multinational companies expanding their global offices. Market forces such as rising fertility challenges, diversity and inclusion initiatives, and employee retention pressures favor Apryl’s growth. By making fertility treatments more accessible and normalized in the workplace, Apryl influences the broader ecosystem toward more holistic employee support[1][2][3].
Looking ahead, Apryl’s acquisition by Progyny positions it for accelerated global expansion and deeper integration of fertility benefits into multinational employer offerings. Trends shaping its journey include increasing demand for personalized reproductive health solutions, regulatory changes supporting family-building benefits, and technological advances in fertility tracking and treatment. Apryl’s influence is likely to grow as it helps redefine workplace benefits, making fertility support a standard part of employee wellness programs worldwide. This aligns with its founding mission to make fertility treatments universally accessible and inclusive, promising a significant impact on how companies support their employees’ family planning needs[2][3].
Apryl has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Seed in April 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2022 | $4.0M Seed | Breega |
